Randomized phase of XanaMIA pivotal trial of oral Xanamem 10 mg remains on track for topline final results in November ...

In a 12-week randomized trial, replacing refined wheat with wholegrain rye in a calorie-restricted diet did not produce ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes ...

A multi-center clinical trial is now enrolling patients to test whether surgically implanted electrodes delivering continuous ...

There are currently no FDA-approved drugs for treating the disorder ...

TIGeR-PaC Trial Enrollment Remains on Track for Completion in First Half of 2026, with Final Data Expected in 2027Select TIGeR-PaC Cancer Centers ...

Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...

GlyphAgo achieved therapeutic exposures of agomelatine at doses projected to avoid liver enzyme elevations and reduce or ...

The trial will allocate participants 1:1:1:1 to receive oral AEF0217 at three dose levels or placebo for 24 weeks. Credit: SmartPhotoLab / Shutterstock.com. Aelis Farma has launched its Phase IIb ...

Researchers have found in PRONTO randomized study that addition of procalcitonin to a sepsis diagnostic algorithm in the emergency department did not delay IV antibiotic administration, but ...